Gland Pharma posts record revenue, nearly doubles profit in Q4 FY26
The 38% adjusted EBITDA margin of base business has been supported by robust growth in the CDMO segment
The 38% adjusted EBITDA margin of base business has been supported by robust growth in the CDMO segment
Medanta expanded its bed capacity by 20% during the year
Backed by Semaglutide launches, the company reported 47% quarter-on-quarter revenue growth in Q4 FY26, with EBITDA expanding more than fivefold
The company witnesses strong growth across its India, Africa, and emerging markets businesses, while securing regulatory approval for the first AB-rated gVentolin in the U.S. market
Global specialty pipeline accelerates growth
Nearly one in five women worldwide are now living with obesity
Net income more than doubled to 2.763 billion euros, while core earnings per share climbed 12.9 percent to 2.71 euros
The decision marks a significant expansion for Pfizer’s once-weekly injectable therapy
We are building an AI-native operating system for pharma sales and distribution
Subscribe To Our Newsletter & Stay Updated